These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15677905)

  • 21. The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review.
    Fraser AG; Orchard TR; Jewell DP
    Gut; 2002 Apr; 50(4):485-9. PubMed ID: 11889067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term results with azathioprine therapy in patients with corticosteroid-dependent Crohn's disease: open-label prospective study.
    Chebli JM; Gaburri PD; De Souza AF; Pinto AL; Chebli LA; Felga GE; Forn CG; Pimentel CF
    J Gastroenterol Hepatol; 2007 Feb; 22(2):268-74. PubMed ID: 17295882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early azathioprine therapy is no more effective than placebo for newly diagnosed Crohn's disease.
    Panés J; López-Sanromán A; Bermejo F; García-Sánchez V; Esteve M; Torres Y; Domènech E; Piqueras M; Gomez-García M; Gutiérrez A; Taxonera C; Sans M;
    Gastroenterology; 2013 Oct; 145(4):766-74.e1. PubMed ID: 23770132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maintenance treatment with azathioprine in ulcerative colitis: outcome and predictive factors after drug withdrawal.
    Cassinotti A; Actis GC; Duca P; Massari A; Colombo E; Gai E; Annese V; D'Albasio G; Manes G; Travis S; Porro GB; Ardizzone S
    Am J Gastroenterol; 2009 Nov; 104(11):2760-7. PubMed ID: 19623172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Azathioprine as a postoperative prophylaxis reduces symptoms in aggressive Crohn's disease.
    Myrelid P; Svärm S; Andersson P; Almer S; Bodemar G; Olaison G
    Scand J Gastroenterol; 2006 Oct; 41(10):1190-5. PubMed ID: 16990204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early azathioprine/biological therapy is associated with decreased risk for first surgery and delays time to surgery but not reoperation in both smokers and nonsmokers with Crohn's disease, while smoking decreases the risk of colectomy in ulcerative colitis.
    Szamosi T; Banai J; Lakatos L; Czegledi Z; David G; Zsigmond F; Pandur T; Erdelyi Z; Gemela O; Papp M; Papp J; Lakatos PL
    Eur J Gastroenterol Hepatol; 2010 Jul; 22(7):872-9. PubMed ID: 19648821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Doppler sonography of the inferior mesenteric artery: a preliminary study.
    Denys AL; Lafortune M; Aubin B; Burke M; Breton G
    J Ultrasound Med; 1995 Jun; 14(6):435-9; quiz 441-2. PubMed ID: 7658511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tioguanine in patients with Crohn's disease intolerant or resistant to azathioprine/mercaptopurine.
    Bonaz B; Boitard J; Marteau P; Lémann M; Coffin B; Flourié B; Belaiche J; Cadiot G; Metman EH; Cortot A; Colombel JF;
    Aliment Pharmacol Ther; 2003 Aug; 18(4):401-8. PubMed ID: 12940925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease: relapse and recapture rates, with predictive factors in 237 patients.
    Kennedy NA; Kalla R; Warner B; Gambles CJ; Musy R; Reynolds S; Dattani R; Nayee H; Felwick R; Harris R; Marriott S; Senanayake SM; Lamb CA; Al-Hilou H; Gaya DR; Irving PM; Mansfield J; Parkes M; Ahmad T; Cummings JR; Arnott ID; Satsangi J; Lobo AJ; Smith M; Lindsay JO; Lees CW
    Aliment Pharmacol Ther; 2014 Dec; 40(11-12):1313-23. PubMed ID: 25284134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tolerance and efficacy of azathioprine in pediatric Crohn's disease.
    Riello L; Talbotec C; Garnier-Lengliné H; Pigneur B; Svahn J; Canioni D; Goulet O; Schmitz J; Ruemmele FM
    Inflamm Bowel Dis; 2011 Oct; 17(10):2138-43. PubMed ID: 21910176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Meta-analysis: the efficacy of azathioprine and mercaptopurine in ulcerative colitis.
    Gisbert JP; Linares PM; McNicholl AG; Maté J; Gomollón F
    Aliment Pharmacol Ther; 2009 Jul; 30(2):126-37. PubMed ID: 19392869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activity of Crohn's disease assessed by measurement of superior mesenteric artery flow with Doppler ultrasound.
    van Oostayen JA; Wasser MN; Griffioen G; van Hogezand RA; Lamers CB; de Roos A
    Neth J Med; 1998 Dec; 53(6):S3-8. PubMed ID: 9883007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 6-tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine.
    Roblin X; Serre-Debeauvais F; Phelip JM; Faucheron JL; Hardy G; Chartier A; Helluwaert F; Bessard G; Bonaz B
    Aliment Pharmacol Ther; 2005 Apr; 21(7):829-39. PubMed ID: 15801918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exclusive enteral nutrition with concomitant early thiopurine use was effective in maintaining steroid-free remission in a Southeast Asian cohort of children with Crohn's disease.
    Ong C; Lim PT; Logarajah V; Liwanag MJ; Ang BX; Cher Y; Chiou FK; Kader A
    BMC Gastroenterol; 2018 Dec; 18(1):185. PubMed ID: 30541458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Azathioprine in inflammatory bowel disease].
    Leite S; Ribeiro JM; Lima SC; Barroso S; Cotter J
    Acta Med Port; 2009; 22(1):33-40. PubMed ID: 19341591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Significant differences between Crohn's disease and ulcerative colitis regarding the impact of body mass index and initial disease activity on responsiveness to azathioprine: results from a European multicenter study in 1,176 patients.
    Holtmann MH; Krummenauer F; Claas C; Kremeyer K; Lorenz D; Rainer O; Vogel I; Böcker U; Böhm S; Büning C; Duchmann R; Gerken G; Herfarth H; Lügering N; Kruis W; Reinshagen M; Schmidt J; Stallmach A; Stein J; Sturm A; Galle PR; Hommes DW; D'Haens G; Rutgeerts P; Neurath MF
    Dig Dis Sci; 2010 Apr; 55(4):1066-78. PubMed ID: 19513841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of 6-mercaptopurine treatment after azathioprine hypersensitivity in inflammatory bowel disease.
    Nagy F; Molnar T; Szepes Z; Farkas K; Nyari T; Lonovics J
    World J Gastroenterol; 2008 Jul; 14(27):4342-6. PubMed ID: 18666323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of azathioprine in mild or moderate relapse in Crohn's disease: clinical and endoscopic evaluation.
    Murakami Y; Matsui T; Hirai F; Takatsu N; Takaki Y; Nagahama T; Hisabe T; Beppu T; Miyaoka M; Maki S; Takeichi M; Nishimura T; Ueki T; Yao K
    Dig Endosc; 2010 Jan; 22(1):25-32. PubMed ID: 20078661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased effectiveness of early therapy with anti-tumor necrosis factor-α vs an immunomodulator in children with Crohn's disease.
    Walters TD; Kim MO; Denson LA; Griffiths AM; Dubinsky M; Markowitz J; Baldassano R; Crandall W; Rosh J; Pfefferkorn M; Otley A; Heyman MB; LeLeiko N; Baker S; Guthery SL; Evans J; Ziring D; Kellermayer R; Stephens M; Mack D; Oliva-Hemker M; Patel AS; Kirschner B; Moulton D; Cohen S; Kim S; Liu C; Essers J; Kugathasan S; Hyams JS;
    Gastroenterology; 2014 Feb; 146(2):383-91. PubMed ID: 24162032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.